期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | PROSTATE CANCER AND PROSTATIC DISEASES LetPub Score 7.4
50 ratings
Rate
Reputation 8.8 Influence 6.3 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | PROSTATE CANCER P D | ||||||||||||||||||||||||
ISSN | 1365-7852 | ||||||||||||||||||||||||
E-ISSN | 1476-5608 | ||||||||||||||||||||||||
h-index | 56 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 13.70%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.nature.com/pcan | ||||||||||||||||||||||||
在線稿件提交 | https://mts-pcan.nature.com/ | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 1997 | ||||||||||||||||||||||||
每年文章數 | 95每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 29.83% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1365-7852%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[PROSTATE CANCER AND PROSTATIC DISEASES] 的評論 | 撰寫評論 |
作者: Nabi2022 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-02-08 19:23:37 評論於 Prostate Specialty Journal, likes novel and innovative articles. Before submission, please self-check according to the Instructions to see if it meets the basic requirements such as format, etc. The speed of the first review is moderate(3) 讚! | Nabi2022 |
作者: 白云锐志 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-14 10:38:40 評論於 If it only takes a few days for a job application to be "Under Consideration," there is usually no need to wait for the final decision as it is likely going to be rejected(0) 讚! | 白云锐志 |
作者: 五郎一凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-13 21:35:44 評論於 I have the same question. I submitted my application but have not received a response. I wonder if I made a mistake in my submission(0) 讚! | 五郎一凡 |
作者: 小野寺雁菱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-22 08:10:21 評論於 Submission rejected on the eighth day(0) 讚! | 小野寺雁菱 |
作者: 小野寺雁菱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-19 13:29:27 評論於 Research focus: Prostate cancer Experience sharing: Submitted on the seventh day, Manuscript Under Consideration on the fourth day(0) 讚! | 小野寺雁菱 |
作者: 是荷紫吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-08 23:13:23 評論於 Is there a confirmation email after submitting a manuscript to this magazine?(0) 讚! | 是荷紫吖 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:18:28 評論於 Calculate the mean using Average(), standard deviation using STDEV.S(), and standard error using STDEV.S()/COUNT()^0.5(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:39:44 評論於 The method of relative quantification in qPCR is ΔΔCT method, which first calibrates with internal reference genes, and then calculates the difference between the sample and the control group(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 18:30:48 評論於 How to deal with the results of qPCR?(0) 讚! | 八坂篷蔚 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:43:50 評論於 How to calculate the margin of error?(0) 讚! | Darlene Pepys |
作者: 仲夏瑞芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-09 12:33:14 評論於 Do siblings who have submitted articles know the submission status of this magazine?(0) 讚! | 仲夏瑞芹 |
作者: 珠星mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-11-02 14:09:17 評論於 Review speed: 2.0 | Submission success rate: 25.0 Experience sharing: This journal has a very small publication volume, with less than 80 articles estimated each year, but receives over 300 submissions(0) 讚! | 珠星mm |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-30 15:55:20 評論於 So stable, a little stronger, isn't it just breaking three points? Really difficult, really difficult(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 17:31:01 評論於 This journal is now rated 2.5, which is a significant increase from last year. Is there a possibility to reach a higher score? Maybe 3?(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us